RisKlick SA

Risklick is shaping the future of clinical trial protocols by offering the first-of-its-kind, AI-based tool for developing high-quality synopsis and optimizing clinical trial protocols efficiently, using historical data. Our AI-based technology enables experts to develop high-quality protocols in a short time, increasing regulatory compliance, recruitment rate and reducing protocol amendments, deviations, and patient burden. Ultimately, Risklick AI identifies protocol weaknesses and suggests optimization prior to the start of the trial. Our AI-powered software is the co-pilot for all the experts involved in protocol development.